Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Einfacher Volltextzugriff von (fast) überall
Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...
    Datensatz exportieren als...
  • BibTeX
The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer
BJU international, 2008-12, Vol.102 (11), p.1531-1538
2008
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
A 1-Year, Open Label, Randomized Phase II Dose Finding Study of Degarelix for the Treatment of Prostate Cancer in North America
The Journal of urology, 2008-11, Vol.180 (5), p.1986-1992
2008
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12‐month, comparative, phase III study
BJU international, 2010-07, Vol.106 (2), p.182-187
2010
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Degarelix monotherapy compared with luteinizing hormone-releasing hormone (LHRH) agonists plus anti-androgen flare protection in advanced prostate cancer: an analysis of two randomized controlled trials
Therapeutic advances in urology, 2016-04, Vol.8 (2), p.75-82
2016
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Efficacy of degarelix in prostate cancer patients following failure on luteinizing hormone-releasing hormone agonist treatment: results from an open-label, multicentre, uncontrolled, phase II trial (CS27)
Therapeutic advances in urology, 2015-06, Vol.7 (3), p.105-115
2015
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
An update on the use of gonadotropin-releasing hormone antagonists in prostate cancer
Therapeutic Advances in Urology, 2011-06, Vol.3 (3), p.127-140
2011
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Disease Control Outcomes from Analysis of Pooled Individual Patient Data from Five Comparative Randomised Clinical Trials of Degarelix Versus Luteinising Hormone-releasing Hormone Agonists
European urology, 2014-12, Vol.66 (6), p.1101-1108
2014
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
The Effect of Baseline Testosterone on the Efficacy of Degarelix and Leuprolide: Further Insights From A 12-Month, Comparative, Phase III Study in Prostate Cancer Patients
Urology (Ridgewood, N.J.), 2012-07, Vol.80 (1), p.174-181
2012
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
A Phase III Extension Trial With a 1-Arm Crossover From Leuprolide to Degarelix: Comparison of Gonadotropin-Releasing Hormone Agonist and Antagonist Effect on Prostate Cancer
The Journal of urology, 2011-09, Vol.186 (3), p.889-897
2011
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Additional Analysis of the Secondary End Point of Biochemical Recurrence Rate in a Phase 3 Trial (CS21) Comparing Degarelix 80 mg Versus Leuprolide in Prostate Cancer Patients Segmented by Baseline Characteristics
European urology, 2010-05, Vol.57 (5), p.836-842
2010
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Long-term Tolerability and Efficacy of Degarelix: 5-Year Results From a Phase III Extension Trial With a 1-Arm Crossover From Leuprolide to Degarelix
Urology (Ridgewood, N.J.), 2014-05, Vol.83 (5), p.1122-1128
2014
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Cardiovascular Safety of Degarelix: Results From a 12-Month, Comparative, Randomized, Open Label, Parallel Group Phase III Trial in Patients With Prostate Cancer
The Journal of urology, 2010-12, Vol.184 (6), p.2313-2319
2010
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Degarelix: A Novel Gonadotropin-Releasing Hormone (GnRH) Receptor Blocker—Results from a 1-yr, Multicentre, Randomised, Phase 2 Dosage-Finding Study in the Treatment of Prostate Cancer
European urology, 2008-10, Vol.54 (4), p.805-815
2008
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Re: Giorgio Gandaglia, Maxine Sun, Jim C. Hu, et al. Gonadotropin-releasing Hormone Agonists and Acute Kidney Injury in Patients with Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.01.026
European urology, 2014-08, Vol.66 (2), p.e34-e35
2014
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Will GnRH antagonists improve prostate cancer treatment?
Trends in endocrinology and metabolism, 2009-01, Vol.20 (1), p.43-50
2009
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Degarelix versus Goserelin (+ Antiandrogen Flare Protection) in the Relief of Lower Urinary Tract Symptoms Secondary to Prostate Cancer: Results from a Phase IIIb Study (NCT00831233)
Urologia internationalis, 2013-01, Vol.90 (3), p.321-328
2013
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Re: 'Use of androgen deprivation therapy in prostate cancer: indications and prevalence' by Connolly et al
Asian journal of andrology, 2012-09, Vol.14 (5), p.795-795
2012
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Re: Lower Testosterone Levels with Luteinizing Hormone-Releasing Hormone Agonist Therapy than with Surgical Castration: New Insights Attained by Mass Spectrometry: T. M. van der Sluis, H. N. Bui, E. J. Meuleman, A. C. Heijboer, J. F. Hartman, N. van Adrichem, E. Boevé, W. de Ronde, R. J. van Moorselaar and A. N. Vis J Urol 2012; 187: 1601–1607
The Journal of urology, 2013-03, Vol.189 (3), p.1168-1169
2013
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Corrigendum to: “Re: The Efficacy and Safety of Degarelix: A 12-Month, Comparative, Randomized, Open-Label, Parallel-Group Phase III Study in Patients with Prostate Cancer” by Dieter Jocham and Christian Doehn [Eur Urol 2009;55:1488–9]
European urology, 2009-11, Vol.56 (5), p.e40-e40
2009
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer: First Analysis of the Early Prostate Cancer Program
The Journal of urology, 2002-08, Vol.168 (2), p.429-435
2002
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Degarelix: A New Approach for the Treatment of Prostate Cancer
Neuroendocrinology, 2009-01, Vol.90 (3), p.235-244
2009
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert review of anticancer therapy, 2009-12, Vol.9 (12), p.1737-1743
2009
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Re: Weckermann D, Harzmann R. Hormone therapy in prostate cancer: LHRH antagonists versus LHRH analogues. Eur Urol 2004;46:279–84
European urology, 2005-03, Vol.47 (3), p.422-422
2005
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Monoclonal antibodies against human prostasomes
The Prostate, 1998-05, Vol.35 (3), p.178-184
1998
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Additional Analysis of the Secondary End Point of Biochemical Recurrence Rate in a Phase 3 Trial (CS21) Comparing Degarelix 80mg Versus Leuprolide in Prostate Cancer Patients Segmented by Baseline Characteristics
European urology, 2010-05, Vol.57 (5), p.836-842
2010
Volltextzugriff (PDF)
1 – 25 von 67
Suche als RSS-Feed
Suchergebnisse filtern
Filter anzeigen
Nur zeigen
Publikationsform
Sprache
Erscheinungsjahr
n.n
n.n
Thema
15 weitere anzeigen...
Weniger anzeigen...
Kollektion
14 weitere anzeigen...
Weniger anzeigen...
Zeitschrift / Serie
5 weitere anzeigen...
Weniger anzeigen...